This company seems to have been delisted
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Albireo Pharma
ALBO
£33.05
Share price
0.00%
Change (1 day)
110.75%
Change (1 year)
Categories
Market capitalization of Albireo Pharma (ALBO)
Last known market cap: £0.68 Billion
On May 5, 2023 Albireo Pharma had a market cap of £0.68 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Albireo Pharma from 2007 to 2023
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2023 | £0.71 B | 94.42% |
| 2022 | £0.36 B | 11.06% |
| 2021 | £0.33 B | -36.68% |
| 2020 | £0.52 B | 112.75% |
| 2019 | £0.24 B | 6.85% |
| 2018 | £0.23 B | 37.22% |
| 2017 | £0.16 B | 86.43% |
| 2016 | £90.41 M | 509.7% |
| 2015 | £14.83 M | -25.98% |
| 2014 | £20.03 M | -31.21% |
| 2013 | £29.12 M | 41.29% |
| 2012 | £20.61 M | 35.68% |
| 2011 | £15.19 M | -51.52% |
| 2010 | £31.33 M | -51.08% |
| 2009 | £64.05 M | -17.86% |
| 2008 | £77.98 M | -67.12% |
| 2007 | £0.23 B |
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | £0.72 B | 6.44% | 🇺🇸 USA |